Buscar
01/07/2022
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe
Amele, S, Sandri, AK, Rodger, A, Vandekerckhove, L, Benfield, T, Milinkovic, A, Duvivier, C, Stellbrink, HJ, Sambatakou, H, Chkhartishvili, N, Caldeira, L, Laguno, M, Domingo, P, Wandeler, G, Gisinger, M, Kuzovatova, E, Dragovic, G, Knysz, B, Matulionyte, R, Rockstroh, JK, Lundgren, JD, Mocroft, A, Peters, L. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13212. PMID:34882940. IF:3.000(Q3/7D).
01/07/2022
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study
Mocroft, A, Miro, JM, Wandeler, G, Llibre, JM, Boyd, A, van Bremen, K, Beniowski, M, Mikhalik, J, Cavassini, M, Maltez, F, Duvivier, C, Foppa, CU, Knysz, B, Bakowska, E, Kuzovatova, E, Domingo, P, Zagalo, A, Viard, JP, Degen, O, Milinkovic, A, Benfield, T, Peters, L. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13210. PMID:34889022. IF:3.000(Q3/7D).
01/02/2022
The endocrine role of brown adipose tissue: An update on actors and actions
Gavalda-Navarro, A, Villarroya, J, Cereijo, R, Giralt, M, Villarroya, F. The endocrine role of brown adipose tissue: An update on actors and actions. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2022; 23(1)DOI:10.1007/s11154-021-09640-6. PMID:33712997. IF:8.200(Q1/1D).
12/01/2022
Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission
Calvet, J, Berenguer-Llergo, A, Gay, M, Massanella, M, Domingo, P, Llop, M, Sanchez-Jimenez, E, Arevalo, M, Carrillo, J, Albinana, N, Arauz-Garofalo, G, Orellana, C, Delgado, JF, Serrano, A, Llobell, A, Graell, E, Garcia-Manrique, M, Moreno, M, Galisteo, C, Casado, E, Navarro, N, Gomez, A, Garcia-Cirera, S, Rusinol, M, Costa, E, Clotet, B, Vilaseca, M, Blanco, J, Gratacos, J. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-021-04683-w. PMID:35022497. IF:4.600(Q2/4D).
15/11/2021
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
Grau-Pujol, B, Camprubi-Ferrer, D, Marti-Soler, H, Fernandez-Pardos, M, Carreras-Abad, C, Velasco-de Andres, M, Ferrer, E, Muelas-Fernandez, M, Jullien, S, Barilaro, G, Ajanovic, S, Vera, I, Moreno, L, Gonzalez-Redondo, E, Cortes-Serra, N, Roldan, M, Artes-de Arcos, A, Mur, I, Domingo, P, Garcia, F, Guinovart, C, Munoz, J. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial. Trials. 2021; 22(1)DOI:10.1186/s13063-021-05758-9. PMID:34781981. IF:2.728(Q4/8D).
01/11/2021
Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19
Alserawan, L, Penacoba, P, Echevarria, SEO, Castillo, D, Ortiz, E, Martinez-Martinez, L, Naranjo, EM, Domingo, P, Castellvi, I, Juarez, C, Mariscal, A. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 2021; 11(11)DOI:10.3390/diagnostics11111998. PMID:34829345. IF:3.992(Q2/4D).